BioSpace News Archive

Spruce Biosciences, Inc. announced that company management will participate in two upcoming investor conferences taking place in June.

Viracta Therapeutics, Inc., a precision oncology company targeting virus-associated malignancies, announced that company management is scheduled to present at the Jefferies Healthcare Conference on Thursday, June 9, 2022, at 1:30 p.m. EDT.

QIAGEN N.V. announced that it welcomed an endorsement from the National Wastewater Surveillance System of the U.S. Centers for Disease Control and Prevention and their validation and approval for the use of two digital PCR systems – including the QIAcuity digital PCR system – for wastewater surveillance of 30 pathogens, including the SARS-CoV-2 virus.

Renovacor, Inc. announced the publication of the results of a preclinical study demonstrating cardiac transduction with low-doses of REN-001 delivered via retrograde coronary sinus infusion in healthy Yucatan pigs.

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that the Company received U.S. Food and Drug Administration (“FDA”) approval for the Abbreviated New Drug Application (ANDA) for Fludrocortisone Acetate Tablets USP, 0.1 mg.

Dr. Huda Zoghbi, pioneering neurologist at Baylor College of Medicine and Texas Children’s Hospital, has been awarded the prestigious 2022 Kavli Prize in the field of neuroscience.

Immunocore Holdings Plc announced that management will present at the following upcoming investor conferences.

ImmunoGen, Inc. announced that on May 31, 2022, the compensation committee of the Company’s Board of Directors approved grants of non-qualified stock option awards to purchase an aggregate of 365,920 shares of its common stock to fourteen new employees under the ImmunoGen, Inc. Inducement Equity Incentive Plan, as amended.

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, announced that it has granted an inducement award to one new employee, Ted Shih, who joined the Company as Head, Clinical Science.

HTG Molecular Diagnostics, Inc. announced that it will be hosting a scientific webinar titled “Integration of the HTG Transcriptome Panel into Preclinical and Clinical Programs to Drive Precision Medicine Research” on June 23, 2022.